Philip Morris International shows robust growth in smoke-free products. Find out why PM stock remains a solid buy with ...

Health regulators at the FDA are struggling to meet review deadlines for medical devices and tobacco products due to recent layoffs. Scientists report doubled workloads and canceled research projects, ...

Philip Morris International has surged 66% in the past ... they care mostly about tax revenue in the end. To this point, the FDA authorized Zyn to market its products in the US in January, and ...

Philip Morris International (PMI) has named Seth Kaufman as chief commercial officer for its U.S. business. He will lead ...

Philip Morris International Inc (NYSE ... Investors love the steady $1.35 quarterly dividend too. The FDA has also greenlit ZYN in the U.S. The consensus price target of $144.56 implies 6% downside.

Meanwhile, the stock price for Philip Morris International Inc., which manufactures ... hard for comprehensive legislation that would give FDA regulatory oversight over tobacco products and ...

Philip Morris International (PMI) has released its sixth annual Integrated Report, highlighting its 10th year of business ...

Tobacco stock investors don't have a lot of choices these days, so if you're looking to invest in one of these classic dividend payers, two of the first stocks that are likely to come up on your radar ...

Swedish Match’s importance within the Philip Morris International portfolio of facilities was evident when it announced a ...

Looking at the financial results head to head, Philip Morris benefits from operating in international markets, where smoking hasn't faced the same degree of regulatory and cultural pushback that ...